Tag: Indian pharma sector

US 100% Tariffs on Branded Pharma Unlikely to Impact Indian Generic Drugs, Says Expert

The tariffs, set to take effect from October 1, 2025, target only branded and patented medicines unless the manufacturing companies establish production facilities in the United States.

September 26, 2025

Trump’s 100% Tariff on Patented Drugs Poses Challenge to India’s $30 Billion Pharma Exports

India’s pharmaceutical industry, often called the “Pharmacy of the World”, supplies over 50 per cent of global vaccine demand, 40 per cent of generics to the US, and 25 per cent of medicines in the UK.

September 26, 2025

Indian Pharmaceutical Market clocks 8% growth in August: Report

The steady momentum was largely supported by chronic therapies, including cardiac, anti-diabetic, and central nervous system (CNS) drugs, alongside strong gains in respiratory and oncology.

September 20, 2025

Indian pharma sector needs price hikes, site and IP transfers to tackle US tariff uncertainty: Report

At the same time, raw material prices are correcting sharply in certain categories, particularly antibiotics, while customers are destocking to take advantage of lower prices.

September 9, 2025